Evidence map›Paper›PMID 28718505›Full record

ReviewImmunology2017

Immunogenomic approaches to understand the function of immune disease variants.

Dafni A Glinos, Blagoje Soskic, Gosia Trynka

Open access · hybridAbstract readReview
In one paragraph

Review in Immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Genotypes, phenotypes and whole genome sequence: Approaches from the My Life Our Future haemophilia project.Haemophilia : the official journal of the World Federation of Hemophilia · 2018
    Review
  4. Enhancers looping to target genes.Nature genetics · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dafni A GlinosWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-5556-0222
Blagoje SoskicWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0003-3173-4528
Gosia TrynkaWellcome Trust Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-6955-9529
Wellcome Sanger Institute · GB

Funding

Wellcome TrustWellcome Trust WT206194
6 · The paper itself

Abstract

Mapping hundreds of genetic variants through genome wide association studies provided an opportunity to gain insights into the pathobiology of immune-mediated diseases. However, as most of the disease variants fall outside the gene coding sequences the functional interpretation of the exact role of the associated variants remains to be determined. The integration of disease-associated variants with large scale genomic maps of cell-type-specific gene regulation at both chromatin and transcript levels deliver examples of functionally prioritized causal variants and genes. In particular, the enrichment of disease variants with histone marks can point towards the cell types most relevant to disease development. Furthermore, chromatin contact maps that link enhancers to promoter regions in a direct way allow the identification of genes that can be regulated by the disease variants. Candidate genes implicated with such approaches can be further examined through the correlation of gene expression with genotypes. Additionally, in the context of immune-mediated diseases it is important to combine genomics with immunology approaches. Genotype correlations with the immune system as a whole, as well as with cellular responses to different stimuli, provide a valuable platform for understanding the functional impact of disease-associated variants. The intersection of immunogenomic resources with disease-associated variants paints a detailed picture of disease causal mechanisms. Here, we provide an overview of recent studies that combine these approaches to identify disease vulnerable pathways.

Indexed as

Chromosome MappingGenetic VariationGenotypeAnimalsGenomicsHumansImmune System Diseasesactivationautoimmunitycell activationgenomics

Identifiers

PMID28718505
PMCPMC5680056
OpenAlexW2737258479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.